Почетна › Множен миелом › Њу Џерси › Edison
Клинички испитувања за Множен миелом во Edison, NJ
22 студии за Множен миелом бараат учесници на локации во и околу Edison (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Се регрутираФаза 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Се регрутираФаза 3
- Astera Cancer Care, East Brunswick · на 6 милји
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Се регрутираФаза 3
- Astera Cancer Care, East Brunswick · на 6 милји
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Се регрутираФаза 3
- MSK Basking Ridge, Basking Ridge · на 15 милји
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Се регрутираФаза 4
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Се регрутираФаза 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Се регрутираФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Се регрутираФаза 3
- MSK Basking Ridge, Basking Ridge · на 15 милји
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Се регрутираФаза 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Се регрутираФаза 3
- Research Site, East Brunswick · на 6 милји
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Се регрутираНабљудувачка студија
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Се регрутираФаза 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Се регрутираФаза 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Се регрутираФаза 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
Се регрутираРана фаза 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · на 3 милји
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Се регрутираФаза 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Се регрутираФаза 1
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · на 3 милји
A Dietary Study for People With Multiple Myeloma
Се регрутира
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Се регрутираФаза 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Се регрутираФаза 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Се регрутира
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
Испитувања за Множен миелом во други градови
- New York City, NY60 студии
- Boston, MA42 студии
- Atlanta, GA41 студија
- Houston, TX38 студии
- Durham, NC37 студии
- Nashville, TN32 студии
- Denver, CO27 студии
- Rochester, MN24 студии
- St. Louis, MO24 студии
- Columbus, OH24 студии
- Baldwin Park, CA23 студии
- Chicago, IL22 студии
Други студии во Edison
- Рак на дојка68 студии
- Рак на бели дробови со не-мали клетки47 студии
- Рак (сите типови)33 студии
- Рак на простата29 студии
- Колоректален карцином23 студии
- Рак на бели дробови23 студии
- Рак на бешиката21 студија
- Метастатски карцином20 студии
- Карцином на јајниците20 студии
- Акутна миелоидна леукемија20 студии
- Рак на ендометриумот19 студии
- Уротелен (транзицисно клеточен) карцином18 студии
Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.